authors
- Sivaraj, Dharshan
- Sullivan, Keith M
- Rizzieri, David A
- Chao, Nelson J
- Gasparetto, Cristina
- Green, Michael M
- Li, Zhiguo
- Anthony Sung, MD
- Sarantopoulos, Stefanie
- Kang, Yubin
- Long, Gwynn D
- Horwitz, Mitchell E
- Lopez, Richard D
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2016
published in
has subject area
- Adult
- Aged
- Antineoplastic Agents
- Bortezomib
- Combined Modality Therapy
- Disease-Free Survival
- Drug Evaluation
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- In Situ Hybridization, Fluorescence
- Kaplan-Meier Estimate
- Lenalidomide
- Maintenance Chemotherapy
- Male
- Middle Aged
- Multiple Myeloma
- Proteasome Inhibitors
- Retrospective Studies
- Thalidomide
- Transplantation, Autologous
- Treatment Outcome